CNR1 and cancer: It would be of utmost importance to identify a possible differential regulation of CB1R and CB2R, also in view of the fact that these two receptor subtypes have been recognized as distinct drug discovery targets for numerous potential therapeutic applications; these include food intake, cancer and immune suppression (Bifulco and Di Marzo, 2002; Piomelli, 2003; Fowler, 2005).